| UHC Surest Medical and Drug | Krystexxa® (Pegloticase) – Commercial Medical Benefit Drug Policy | 2025-11-01 |
| UHC Surest Medical and Drug | Leqvio® (Inclisiran) – Commercial Medical Benefit Drug Policy | 2025-11-01 |
| UHC Surest Medical and Drug | Self-Administered Medications – Commercial Medical Benefit Drug Policy | 2025-11-01 |
| UHC Surest Medical and Drug | Synagis® (Palivizumab) – Commercial Medical Benefit Drug Policy | 2025-11-01 |
| BCBS North Carolina | Allergy Immunotherapy (Desensitization) | Providers | 2025-11-01 |
| BCBS North Carolina | Bioimpedance Devices for Detection of Lymphedema | Providers | 2025-11-01 |
| BCBS North Carolina | Chromoendoscopy as an Adjunct to Colonoscopy | Providers | 2025-11-01 |
| BCBS North Carolina | Confocal Laser Endomicroscopy | Providers | 2025-11-01 |
| BCBS North Carolina | Electronic Brachytherapy for Nonmelanoma Skin Cancer | Providers | 2025-11-01 |
| BCBS North Carolina | Electrostimulation and Electromagnetic Therapy for Wounds | Providers | 2025-11-01 |